Filter Results :

Your search for Cancer Drug Market returned 110 reports

Sort by


North America Cancer Treatment Drugs Market by Manufacturers, Countries, Type and Application, Forecast to 2022

10 Jan 2018  |  Published by:  Global Info Research
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.Scope of the Report:This report focuses on the Cancer Treatment Drugs in ...

$ 4,480.00

Read More

Global Human Microbiome Market (By Diseases - Cancer, Diabetes, Obesity, Acute Diarrhea or Metabolic Disorders, Autoimmune Disorders, Mental Disorders, Atopic Dermatitis and other diseases, By Technology- Cell Culture Technology, Omics Technology, High-Throughput Technology and Computational Tools, By Product - Consumables and Instruments, By End-Use - Prebiotics, Probiotics, Other Probiotic Supplements, Foods, Medical Foods, drugs and Diagnostic services) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 - 2025

01 Jan 2018  |  Published by:  Sheer Analytics & Insights
The report covers the analysis and forecast of the global human microbiome market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Million).The study provides a detailed view of the global...

$ 4,795.00

Read More

Global Colorectal Cancer Drugs Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

17 Nov 2017  |  Published by:  Precision Business Insights
Colorectal cancer is also known as bowel cancer. It refers to the abnormal growth of the cells in colon and rectum due to cancer. Colorectal cancer starts either in the colon and rectum. Cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Some ...

$ 4,400.00

Read More

3D Cell Culture Market by Product (Scaffold-free (Hanging Drop, Bioreactor), Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell Research, Drug Discovery), End User (Pharmaceutical, Biotech, Research) - Global Forecast to 2022

08 Nov 2017  |  Published by:  MarketsandMarkets
Global 3D cell culture market projected to grow at a CAGR of 20.3%The 3D cell culture market is expected to reach USD 1,702.3 million by 2022 from USD 682.8 million in 2017, at a CAGR of 20.3%. The rising focus on developing alternative methods for animal testing, funding initiatives from government...

$ 5,650.00

Read More

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Recurrent Head And Neck Cancer Squamous Cell Carcinoma. The report inc...

$ 2,000.00

Read More

Nasopharyngeal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, Nasopharyngeal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Nasopharyngeal Cancer. The report includes information of marketed products including their product des...

$ 1,500.00

Read More

Human papillomavirus (HPV) Associated Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, Human papillomavirus (HPV) Associated Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Human papillomavirus (HPV) Associated Cancer. The report includes information of...

$ 2,000.00

Read More

Epithelial Ovarian Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, Epithelial Ovarian Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Epithelial Ovarian Cancer. The report includes information of marketed products including their pro...

$ 2,000.00

Read More

Thyroid Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, Thyroid Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Thyroid Cancer. The report includes information of marketed products including their product description, pate...

$ 2,000.00

Read More

Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Nov 2017  |  Published by:  DelveInsight
Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Testicular Cancer Report is to understand the ...

$ 2,000.00

Read More

Small-Cell Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Nov 2017  |  Published by:  DelveInsight
Small-Cell Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Small-Cell Lung Cancer Report is to under...

$ 2,000.00

Read More

Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Nov 2017  |  Published by:  DelveInsight
Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Pancreatic Cancer Report is to understand the ...

$ 2,000.00

Read More

Metastatic Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Nov 2017  |  Published by:  DelveInsight
Metastatic Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Metastatic Pancreatic Cancer Report...

$ 2,000.00

Read More

Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Nov 2017  |  Published by:  DelveInsight
Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Metastatic Ovarian Cancer Report is to...

$ 2,000.00

Read More

Metastatic Nonseminomatous Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Nov 2017  |  Published by:  DelveInsight
Metastatic Nonseminomatous Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Metastatic Nonsemin...

$ 2,000.00

Read More
Total 110 records.